National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease
- PMID: 18458271
- DOI: 10.7326/0003-4819-148-12-200806170-00220
National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical